Cargando…

Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial

Losartan has become a hot spot in the treatment of non-alcoholic fatty liver disease (NAFLD) among angiotensin receptor blocker drugs. We sought to conduct a systematic examination and meta-analysis to examine the effects of losartan on patients with NAFLD. We searched for potentially randomized con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Chang, Song, Zejun, Zhang, Lingnan, Geng, Yu, Sun, Jing, Miao, Guobin, Liu, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031500/ https://www.ncbi.nlm.nih.gov/pubmed/36970603 http://dx.doi.org/10.1515/biol-2022-0583

Ejemplares similares

Randomized placebo‐controlled trial of losartan for pediatric NAFLD
por: Vos, Miriam B., et al.
Publicado: (2022)

Losartan Prevents Hepatic Steatosis and Macrophage Polarization by Inhibiting HIF-1α in a Murine Model of NAFLD
por: Wang, Cheng-Hui, et al.
Publicado: (2021)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Losartan for Preventing Aortic Root Dilatation in Patients with Marfan Syndrome: A Meta-Analysis of Randomized Trials
por: Elbadawi, Ayman, et al.
Publicado: (2019)

Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial
por: Mao, Wei, et al.
Publicado: (2021)

Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial
por: Radonic, Teodora, et al.
Publicado: (2010)

Efficacy of Losartan in the management of Post-Dialysis Euvolemic Hypertension (HELD-Trial): A Single-Blind Randomized Control Trial
por: Aftab, Raja Ahsan, et al.
Publicado: (2016)

Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease
por: Mao, Wei, et al.
Publicado: (2015)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

Abelmoschus manihot – a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial
por: Li, Ping, et al.
Publicado: (2017)

A pilot clinical trial with losartan in Myhre syndrome
por: Cappuccio, Gerarda, et al.
Publicado: (2020)

Lipid Disorders in NAFLD and Chronic Kidney Disease
por: Yang, Meng, et al.
Publicado: (2021)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial
por: van Andel, Mitzi M, et al.
Publicado: (2020)

Effect of losartan on Doppler sonography indices in kidney transplant patients: A randomized clinical trial
por: Nouri-Majalan, Nader, et al.
Publicado: (2009)

A Randomized, Double-Blind Trial of Lisinopril and Losartan for the Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy
por: Allen, Hugh D., et al.
Publicado: (2013)

COVIDMED – An early pandemic randomized clinical trial of losartan treatment for hospitalized COVID-19 patients
por: Freilich, Daniel, et al.
Publicado: (2022)

Nephroprotective effect of losartan in IgA model rat
por: Xing, Li, et al.
Publicado: (2019)

A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis
por: McPherson, Stuart, et al.
Publicado: (2017)

Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease
por: Vos, Miriam B., et al.
Publicado: (2018)

The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Stachowska, Ewa, et al.
Publicado: (2020)

Correction: A Randomized, Double-Blind Trial of Lisinopril and Losartan for the Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy
Publicado: (2015)

A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19
por: Puskarich, Michael A., et al.
Publicado: (2021)

Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan
por: Citterio, Lorena, et al.
Publicado: (2021)

Efficacy of Losartan in Hospitalized Patients With COVID-19–Induced Lung Injury: A Randomized Clinical Trial
por: Puskarich, Michael A., et al.
Publicado: (2022)

Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial
por: Castilla‐Ojo, Noelle, et al.
Publicado: (2023)

Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial
por: Yoneda, Masato, et al.
Publicado: (2022)

Biological Effects of Hydrogen Water on Subjects with NAFLD: A Randomized, Placebo-Controlled Trial
por: Kura, Branislav, et al.
Publicado: (2022)

The Relationship between NAFLD and Sarcopenia in Elderly Patients
por: Zhai, Yu, et al.
Publicado: (2018)

Effect of Nutrition Education in NAFLD Patients Undergoing Simultaneous Hyperlipidemia Pharmacotherapy: A Randomized Controlled Trial
por: Lee, Won Myung, et al.
Publicado: (2021)

Efficacy and safety of baricitinib for the treatment of hospitalized adults with COVID-19: a systematic review and meta-analysis
por: Sun, Jing, et al.
Publicado: (2023)

RYGB increases postprandial gastric nesfatin-1 and rapid relieves NAFLD via gastric nerve detachment
por: Wang, Geng, et al.
Publicado: (2020)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

Losartan Alleviates the Side Effects and Maintains the Anticancer Activity of Axitinib
por: Fu, Ying, et al.
Publicado: (2022)

Limited Clinical Utility of Remote Ischemic Conditioning in Renal Transplantation: A Meta-Analysis of Randomized Controlled Trials
por: Zhou, Chang-Cheng, et al.
Publicado: (2017)

Remote Ischemic Postconditioning for Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhao, Jing-Jing, et al.
Publicado: (2018)

Safety and Efficacy of Losartan 50 mg in Reducing Blood Pressure among Patients with Post-Dialysis Euvolemic Hypertension: A Randomized Control Trial
por: Aftab, Raja Ahsan, et al.
Publicado: (2017)

Losartan Attenuates Insulin Resistance and Regulates Browning Phenomenon of White Adipose Tissue in ob/ob Mice
por: Liu, Hsuan-Miao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aa5jsrnig696hggvb4db79l0k2